BiZact™ has been built for one purpose and designed in collaboration with ENTs, to optimize tonsillectomies with clinically proven benefits for you and more importantly, your patients.
The BiZact™ device has been clinically shown to:
Surgeons using the BiZact™ device are completing cases in about half the time1,4,5,†† compared to the Coblator™* device and electrocautery. Because the BiZact™ device:
† Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml [Lachanas] with cold knife.
†† Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss.
‡ Used in 48 cases, including adults (22+) US (18+) EU. Average procedure time for the BiZact™ tonsillectomy device was 7 min. compared to published literature stating 14.8 (pediatric) and 20.5 (adult) min. [Lee] for electrocautery and 27.3 min. [Omrani] for Coblator™*.
§ Used in 60 cases, including patients (age range 3‑12yrs) in the U.S. There were no intra‑operative or post‑operative bleeding events, defined as bleeding events that required intervention, compared to secondary post‑operative hemorrhage rates in published literature of 6.3% for electrocautery, 4% for cold dissection, and 2.4% for coblation [Francis].
§§ Used in 48 cases, including adults (22+) US (18+) EU. The use of the BiZact™ tonsillectomy device resulted in non‑measurable blood loss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml for cold knife [Lachanas].
₤ 12 out of 12 surgeons and 13 out of 15 nurses surveyed agreed.
Ω Compared to electrocautery, Coblator™*, and cold knife.